COVID-19 disease. COVID-19, virus identified
Conditions
Interventions
Intervention 1: Intervention group:The patients will receive 10 ml of elderberry extract syrup 3 times daily (2.6 g of elderberry extract per day equivalent to 15.76 g of fresh elderberries) beside th
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: A definitive diagnosis of COVID-19 infection based on laboratory confirmation (lymphocytopenia, increased quantitative CRP, chest X-ray results) and clinical symptoms of patients including fever, coughs and myalgia Outpatients and home quarantined patients
Exclusion criteria
Exclusion criteria: Hospitalization Age> 65 y and <18 y Patients with catheter Patients receiving chemotherapy drugs, corticosteroids and theophylline Autoimmunity Gastrointestinal diseases Migraine Diabetes Hypokalemia Myalgia Respiratory diseases Smoking Pregnancy and breast feeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fever. Timepoint: Days 3, 7 and 14 after the intervention beginning. Method of measurement: Thermometer.;Shortness of breath. Timepoint: Days 3, 7 and 14 after the intervention beginning. Method of measurement: Autosaturation device, Counting the number of breaths in 1 minute.;Coughs. Timepoint: Days 3, 7 and 14 after the intervention beginning. Method of measurement: Patient follow up.;Myalgia. Timepoint: Days 3, 7 and 14 after the intervention beginning. Method of measurement: Patient follow up. | — |
Secondary
| Measure | Time frame |
|---|---|
| Lymphocytopenia. Timepoint: days 3, 7 and 14 after the intervention beginning. Method of measurement: Cell counter.;C-reactive protein. Timepoint: days 3, 7 and 14 after the intervention beginning. Method of measurement: CRP kit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyed Ahmad Emami
Mashhad University of Medical Sciences
Outcome results
None listed